These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
244 related items for PubMed ID: 24211059
1. Effect of cilostazol in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. Niu PP, Yang G, Xing YQ, Guo ZN, Yang Y. J Neurol Sci; 2014 Jan 15; 336(1-2):146-51. PubMed ID: 24211059 [Abstract] [Full Text] [Related]
2. Effect of statin treatment on vasospasm-related morbidity and functional outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. Shen J, Huang KY, Zhu Y, Pan JW, Jiang H, Weng YX, Zhan RY. J Neurosurg; 2017 Aug 15; 127(2):291-301. PubMed ID: 27715439 [Abstract] [Full Text] [Related]
3. Effect of Cilostazol on Cerebral Vasospasm and Outcome in Patients with Aneurysmal Subarachnoid Hemorrhage: A Randomized, Double-Blind, Placebo-Controlled Trial. Matsuda N, Naraoka M, Ohkuma H, Shimamura N, Ito K, Asano K, Hasegawa S, Takemura A. Cerebrovasc Dis; 2016 Aug 15; 42(1-2):97-105. PubMed ID: 27070952 [Abstract] [Full Text] [Related]
4. Dissociation of vasospasm-related morbidity and outcomes in patients with aneurysmal subarachnoid hemorrhage treated with clazosentan: a meta-analysis of randomized controlled trials. Shen J, Pan JW, Fan ZX, Xiong XX, Zhan RY. J Neurosurg; 2013 Jul 15; 119(1):180-9. PubMed ID: 23641823 [Abstract] [Full Text] [Related]
5. Effects of cilostazol on cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a multicenter prospective, randomized, open-label blinded end point trial. Senbokuya N, Kinouchi H, Kanemaru K, Ohashi Y, Fukamachi A, Yagi S, Shimizu T, Furuya K, Uchida M, Takeuchi N, Nakano S, Koizumi H, Kobayashi C, Fukasawa I, Takahashi T, Kuroda K, Nishiyama Y, Yoshioka H, Horikoshi T. J Neurosurg; 2013 Jan 15; 118(1):121-30. PubMed ID: 23039152 [Abstract] [Full Text] [Related]
6. Cilostazol reduces morbidity but not mortality secondary to cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Ding D. J Neurol Sci; 2014 May 15; 340(1-2):243-4. PubMed ID: 24690347 [No Abstract] [Full Text] [Related]
7. Effectiveness and feasibility of cilostazol in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. Shan T, Zhang T, Qian W, Ma L, Li H, You C, Xie X. J Neurol; 2020 Jun 15; 267(6):1577-1584. PubMed ID: 30739182 [Abstract] [Full Text] [Related]
8. Efficacy of Cilostazol in Prevention of Delayed Cerebral Ischemia after Aneurysmal Subarachnoid Hemorrhage: A Meta-Analysis. Saber H, Desai A, Palla M, Mohamed W, Seraji-Bozorgzad N, Ibrahim M. J Stroke Cerebrovasc Dis; 2018 Nov 15; 27(11):2979-2985. PubMed ID: 30093204 [Abstract] [Full Text] [Related]
9. Treatment of cerebral vasospasm following aneurysmal subarachnoid haemorrhage: a systematic review and meta-analysis. Boulouis G, Labeyrie MA, Raymond J, Rodriguez-Régent C, Lukaszewicz AC, Bresson D, Ben Hassen W, Trystram D, Meder JF, Oppenheim C, Naggara O. Eur Radiol; 2017 Aug 15; 27(8):3333-3342. PubMed ID: 28004163 [Abstract] [Full Text] [Related]
10. Endothelin receptor antagonists for aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis update. Vergouwen MD, Algra A, Rinkel GJ. Stroke; 2012 Oct 15; 43(10):2671-6. PubMed ID: 22871682 [Abstract] [Full Text] [Related]
11. An Update on the Efficacy and Safety Profile of Clazosentan in Cerebral Vasospasm After Aneurysmal Subarachnoid Hemorrhage: A Meta-Analysis. Song J, Xue YQ, Wang YJ, Xu P, Sun DK, Chen W. World Neurosurg; 2019 Mar 15; 123():e235-e244. PubMed ID: 30496924 [Abstract] [Full Text] [Related]
12. Cilostazol for Aneurysmal Subarachnoid Hemorrhage: An Updated Systematic Review and Meta-Analysis. Liu J, He J, Chen X, Feng Y, Wang C, Awil MA, Wang Y, Tian Y, Hou D. Cerebrovasc Dis; 2022 Mar 15; 51(2):138-148. PubMed ID: 35288494 [Abstract] [Full Text] [Related]
13. Cilostazol Administration for Subarachnoid Hemorrhage: A Meta-analysis of Randomized Controlled Trials. Chen H, Luo W, Cai X, Cai J. Clin Neuropharmacol; 2022 Mar 15; 45(5):111-116. PubMed ID: 36162042 [Abstract] [Full Text] [Related]
14. Cilostazol improves outcome after subarachnoid hemorrhage: a preliminary report. Suzuki S, Sayama T, Nakamura T, Nishimura H, Ohta M, Inoue T, Mannoji H, Takeshita I. Cerebrovasc Dis; 2011 Mar 15; 32(1):89-93. PubMed ID: 21677432 [Abstract] [Full Text] [Related]
15. Metaanalysis of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage. Jang YG, Ilodigwe D, Macdonald RL. Neurocrit Care; 2009 Mar 15; 10(1):141-7. PubMed ID: 18810661 [Abstract] [Full Text] [Related]
16. Effect of simvastatin in patients with aneurysmal subarachnoid hemorrhage: A systematic review and meta-analysis. Liu H, Xu X. Am J Emerg Med; 2017 Dec 15; 35(12):1940-1945. PubMed ID: 28966073 [Abstract] [Full Text] [Related]
17. Cilostazol attenuates cerebral vasospasm after experimental subarachnoid hemorrhage. Nishino A, Umegaki M, Fujinaka T, Yoshimine T. Neurol Res; 2010 Oct 15; 32(8):873-8. PubMed ID: 20350366 [Abstract] [Full Text] [Related]
18. Role of Cilostazol in Prevention of Vasospasm After Aneurysmal Subarachnoid Hemorrhage-A Systematic Review, Meta-Analysis, and Trial Sequential Analysis. Bohara S, Garg K, Singh Rajpal PM, Kasliwal M. World Neurosurg; 2021 Jun 15; 150():161-170. PubMed ID: 33631387 [Abstract] [Full Text] [Related]
19. Clazosentan for Aneurysmal Subarachnoid Hemorrhage: An Updated Meta-Analysis with Trial Sequential Analysis. Cho SS, Kim SE, Kim HC, Kim WJ, Jeon JP. World Neurosurg; 2019 Mar 15; 123():418-424.e3. PubMed ID: 30508597 [Abstract] [Full Text] [Related]
20. Effect of clazosentan in patients with aneurysmal subarachnoid hemorrhage: a meta-analysis of randomized controlled trials. Wang X, Li YM, Li WQ, Huang CG, Lu YC, Hou LJ. PLoS One; 2012 Mar 15; 7(10):e47778. PubMed ID: 23082215 [Abstract] [Full Text] [Related] Page: [Next] [New Search]